Health Care: Drugs

Ligand Pharmaceuticals Inc (LGND: NASDAQ)

$121.42 3.78 | 3.21%
06/29/16 - 03:59 PM ET
Company Profile
Price and Volume
Recent Price 121.42
52 Week High 131.84
52 Week Low 71.63
Avg. Daily Vol. (Mil) 0.38
Beta (3 year) 0.84
Share Related Items
Mkt Cap (Mil) 2,528.26
Shares Out (Mil) 20.82
Float (Mil) 18.82
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 10.20
Current Ratio 10.30
LT Debt/ Equity 0.67
Total Debt / Equity 0.68
Valuation Ratios
Price Earnings 10.00
Price/Sales 29.07
Price/Book 8.31
Price/Cash Flow 9.40
Per Share Data
Earnings 12.20
Sales 4.18
Book Value 14.62
Cash Flow 12.86
Business Summary
Ligand Pharmaceuticals Inc is a biopharmaceutical company with a business model that is based upon the concept of developing or acquiring royalty revenue generating assets and coupling them with a lean corporate cost structure.
General Information
11119 North Torrey Pines Roa
Suite 200
La Jolla, CA 92037
www.ligand.com
Industry : Drugs
Sector: Health Care
Employees: 21
CEO: Mr. John L. Higgins
Short Interest
Current Month (Mil) 3.88
Previous Month (Mil) 3.92
Short Interest Ratio (Days) 12.40
Management Effectiveness
Return on Equity 83.70
Return on Assets 47.70
Return on Investments 50.00
Profitability
Gross Margin 91.90
EBIT Margin 47.60
Profit Margin 0.00

Portfolios with LGND

Latest LGND Headlines from TheStreet

More Financial News for LGND

Press Releases for LGND

See All Press Releases

Partner Headlines for LGND

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter